Neurenati develops novel therapies for GI rare pediatric diseases
Company Details
- Employees
- 9
- Founded
- -
- Address
- 630 Boul René-Lévesque West 20th Floor, Montreal,quebec H3b 1s6,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.neurenati.com
- Keywords
- Neuro-regeneration, gastroenterology, Pediatric, Rare diseases, Hirschsprung, Neurosciences.
- HQ
- Montreal, Quebec
Neurenati Therapeutics Questions
Neurenati Therapeutics's website is http://www.neurenati.com
Neurenati Therapeutics's LinkedIn profile is https://ca.linkedin.com/company/neurenati
Neurenati Therapeutics has
9 employees.
View email and phone details for 9
employees at Neurenati Therapeutics.
Neurenati Therapeutics's industry is
Biotechnology Research
Neurenati Therapeutics's top competitors are
Epibone, Inc.,
Pulsesight Therapeutics,
Synthis Therapeutics, Inc.,
Ten30 Biosciences Inc,
Fimmcyte,
Genethon,
Script Biosciences,
Cerecura Nanotherapeutics,
Rhythm Biotherapeutics Inc.,
Apiary Therapeutics.
Neurenati Therapeutics's categories are Biotechnology Research
Neurenati Therapeutics's founding year is 2020
